Emapalumab Effectively Controls MAS in Patients With Lupus

Patients substantially reduce their average steroid dose and report MAS events for 1 year.
Medscape Medical News

Source link : https://www.medscape.com/viewarticle/emapalumab-effectively-controls-mas-patients-lupus-who-2026a100091x?src=rss

Author :

Publish date : 2026-03-25 08:23:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
				1	2	3
4	5	6	7	8	9	10
11	12	13	14	15	16	17
18	19	20	21	22	23	24
25	26	27	28	29	30	31

Emapalumab Effectively Controls MAS in Patients With Lupus

FDA Approves Higher Dose Shot for Greater Weight Loss

Delaying Pegfilgrastim May Curb Bone Pain in Breast Cancer

Related Posts

Cosmetic-Related Eye Injuries in Kids Up Since 2020

Why Some Centenarians Maintain Younger Immune Systems

Trump, Kennedy Seek to Relax AI Healthcare Safeguards Rules

Mystery of the ancient giant stone jars of Laos may have been solved

HHS Panel That Aims to Reshape U.S. Healthcare Holds Its First Meeting

CDC Places Limits on U.S. Entry as Deaths Top 100 in Ebola Outbreak

Cosmetic-Related Eye Injuries in Kids Up Since 2020

Why Some Centenarians Maintain Younger Immune Systems

Trump, Kennedy Seek to Relax AI Healthcare Safeguards Rules

Mystery of the ancient giant stone jars of Laos may have been solved

HHS Panel That Aims to Reshape U.S. Healthcare Holds Its First Meeting

CDC Places Limits on U.S. Entry as Deaths Top 100 in Ebola Outbreak

Leucovorin Scripts Surged Even Before White House Autism Push

American Doctor Has Ebola, Will Be Transferred for Care

Categories

Archives